MARKET

SGHT

SGHT

Sight Sciences, Inc.
NASDAQ
9.02
+0.03
+0.33%
After Hours: 9.06 +0.04 +0.47% 19:30 10/26 EDT
OPEN
8.97
PREV CLOSE
8.99
HIGH
9.18
LOW
8.88
VOLUME
267.95K
TURNOVER
--
52 WEEK HIGH
9.71
52 WEEK LOW
3.378
MARKET CAP
496.89M
P/E (TTM)
-16.2055
1D
5D
1M
3M
1Y
5Y
1D
Press Release: Sight Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026
Dow Jones · 5d ago
Weekly Report: what happened at SGHT last week (1012-1016)?
Weekly Report · 10/19 10:24
HC Wainwright & Co. Initiates Coverage of Sight Sciences with Buy
NASDAQ · 10/16 01:23
Sight Sciences Price Target Announced at $14.00/Share by HC Wainwright & Co.
Dow Jones · 10/15 22:38
Sight Sciences Initiated at Buy by HC Wainwright & Co.
Dow Jones · 10/15 22:38
Why Is Sight Sciences Stock Gaining Thursday?
Benzinga · 10/15 17:53
This Eloxx Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Benzinga · 10/15 12:06
HC Wainwright & Co. Initiates Coverage On Sight Sciences with Buy Rating, Announces Price Target of $14
Benzinga · 10/15 10:54
More
About SGHT
Sight Sciences, Inc. is an eyecare technology company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company operates through two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, which is an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, and the SION Surgical Instrument is a bladeless, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The product portfolio for the Dry Eye segment consists of the TearCare System (TearCare) for ophthalmologists and optometrists. TearCare is used by adult patients with evaporative dry eye disease due to meibomian gland disease (MGD), enabling clearance of gland obstructions by physicians to address the cause of dry eye disease.

Webull offers Sight Sciences Inc stock information, including NASDAQ: SGHT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SGHT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SGHT stock methods without spending real money on the virtual paper trading platform.